Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Cardiovascular / Cardiology News

Ventracor (ASX:VCR) Announces European Approval For New Version VentrAssist LVAD

Main Category: Cardiovascular / Cardiology
Also Included In: Regulatory Affairs / Drug Approvals;  Medical Devices / Diagnostics
Article Date: 19 Dec 2007 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Ventracor (ASX: VCR) announced CE Marking approval for the next version of the VentrAssist(tm) left ventricular assist device (LVAD) which allows it to be marketed and sold in Europe.

The US Food & Drug Administration (FDA) approved use of the new version earlier this week.

The new version VentrAssist (called LVA4) was first implanted in Australia under the Special Access Scheme (SAS) and an application for full approval is with the Australian Therapeutic Goods Administration for review.

Ventracor Chief Executive Peter Crosby said, "The enhanced VentrAssist will help us continue to meet the needs of our partner cardiologists and surgeons and help them achieve better clinical outcomes for their heart failure patients.

The new version uses the proven VentrAssist blood pump with a thinner percutaneous lead (the wire from the pump that goes through the skin) which it is hoped will lower the risk of inf! ection. It also has a replaceable external extension wire to t! he contr oller. This allows the external part of the wire to be replaced in case of inadvertent damage or wear from normal long term use. A new more flexible outflow cannula (the tube that directs blood from the pump to the aorta) allows greater surgical flexibility for different patient sizes and conditions. Ventracor has also updated the range of inflow cannulae sizes and surgical tools.

About Ventracor Limited

Ventracor is a global medical device company which produces an implantable blood pump, the VentrAssist left ventricular assist device (LVAD), as a therapy to improve the lives of heart failure patients. Ventracor is dedicated to building partnerships with healthcare professionals to make the VentrAssist the standard-of-care worldwide.

http://www.ventracor.com/




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Low Blood Pressure? What Is Hypotension?
03 Aug 2009
Low blood pressure is also known as hypotension. For millions of people who suffer from hypertension (high blood pressure) hypotension may seem great. If symptoms are mild hypotension usually requires no treatment...


Stress and Sports image Stress and Sports

Many people turn to sports to unwind, but the pressure of competition can turn otherwise relaxing pursuits into sources of stress (and affect your game, too). Our panel of experts will discuss what you can do to make sure your sports life helps, rather than hurts, your state of mind...

Life After a Heart Transplant image Life After a Heart Transplant

Heart transplant success is determined by your post-surgery quality of life. Successful patients are able to resume activities they enjoyed before the procedure, such as moderate exercise and sexual activity. Join Dr. Mehmet Oz and ex-baseball star and donor-heart recipient Frank Torre, as they...

View more videos...